This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...
Chimeric antigen receptor (CAR) T-cell therapy has demonstrated promising outcomes in treating leukemia, yet it confronts significant hurdles due to severe side effects like cytokine release syndrome ...
1Peter MacCallum Cancer Centre, Melbourne, Australia. 2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia. 3Collaborative Centre for Genomic Medicine, Peter ...
1Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China. 2Department of Pathology and Frontier Innovation Center, School of Basic Medicine Sciences ...
1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins University School of Medicine, Baltimore, ...
1School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 2Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, ...
1The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: Timothy Yap, Department for Investigational Cancer Therapeutics (Phase I Program), Division of Cancer ...
1Laboratory of Rare Human Circulating Cells (LCCRH) and Liquid Biopsy, University Medical Centre of Montpellier, Montpellier, France. 2CREEC (CREES), Unité Mixte de Recherches, IRD 224–CNRS ...
1Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. 2Department of Urology, Henan Institute of Urology and Zhengzhou Key Laboratory for Molecular Biology of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results